Metabolic Complications Following Knee Injury in Young and Middle Aged Patients

NCT ID: NCT02573662

Last Updated: 2015-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-04-30

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction This study evaluates the effect on glucose, lipid and bone metabolism following knee orthopedic procedures in healthy and physically active individuals. The sedentary rehabilitation period following these procedures may impact negatively on glucose, lipid and bone metabolic pathways, whereas the more physically active rehabilitation period instituted 6 weeks after surgery is hypothesized to impact positively.

Perspective This study will establish whether the well-known effects on glucose, lipid and bone metabolism of a sedentary lifestyle can be observed already following 6 weeks of physical inactivity in otherwise healthy and physically fit young and middle aged individuals. Investigators will thereby add knowledge to previous findings following strict bed-rest in healthy individuals on glucose, lipid and bone metabolism. In a clinical perspective it is important to examine the extent to which healthy individuals deteriorate in various metabolic pathways to better understand the pathophysiology behind these defects both in healthy individuals and in patients, who undergo bed rest or an equal reduction in physical activity as part of their rehabilitation.

Study design 16 physical active non-diabetic individuals of age 18 - 50 years who are undergoing knee surgical procedures at the Arthroscopic Center at Amager/Hvidovre Hospitals are recruited as cases for this case-control study.

10 non-diabetic control subjects matched for age, gender and physical activity are recruited to establish a reference level.

* The individuals will bring in morning spot urine for measurement of soluble urokinase plasminogen activating receptor (suPAR), creatinine, albumin and orosomucoid. Weight and height and waist and hip circumference will be measured.
* Oral glucose tolerance test (OGTT) with ingestion of 75 g glucose during 5 min from baseline (0 min). Plasma for glucose, insulin, C-peptide, non-esterified fatty acid (NEFA) will be drawn
* Before OGTT blood will be drawn for measurement of HbA1c, total cholesterol, LDL, HDL, triglyceride, Na, K, creatinine, hemoglobin (HgB), C-reactive protein (CRP), leukocytes, alanintransaminase (ALAT), alkaline phosphatase, Ca++, D vitamin, TSH, bone turnover markers (BTM), suPAR, interleukin 6 (IL6), TNFa, high-sensitivity C-reactive protein (hsCRP), lipid density profiling and lipid particle size.
* Dual energy X-ray absorptiometry (DXA) of hip, lumbar columna, visceral and subcutaneous fat is measured by Hologic Discovery scanner.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypothesis Implementation of a sedentary lifestyle with almost no physical activity in otherwise physical active individuals undergoing knee orthopaedic surgical procedures will during 6 weeks (4 to 8 weeks)

* derange insulin sensitivity and glucose effectiveness
* decrease disposition index
* imply hyper-secretion of incretin hormones and glucagon
* compensatory decrease in insulin clearance
* decrease lipid oxidation
* increase visceral adipose tissue
* increase number of low density lipoprotein particles and a decrease the particle size
* increase immune and low grade inflammatory response as measured in plasma and urine
* induce bone loss in hip as measured by bone mineral density (BMD)
* increase bone resorption and decrease bone formation as measured by selected bone turnover markers.

The proposed negative changes in bone, lipid and glucose metabolism are thought to reverse at least partly so, during active physical rehabilitation during week 6 through week 16.

Statistics Ten days of bed rest in 13 healthy young individuals showed a 20% (P\<0.05) significant decrease in insulin sensitivity and a 50% (P\<0.05) reduction in lipid oxidation. Thirty-one days of bed rest in 8 healthy women was significantly associated with bone loss in total hip (2.07%, P\<0.001).

As the present study does not imply strict bed rest but exhibit a longer sedentary period of following up as the above studies and include a larger number of participants we are very likely to exhibit a power \> 80% at significance level

Ethical issues The study is approved by the local scientific ethical committee and the Danish Data Protection Agency. The study adheres to the Danish Act on Processing of Personal Data and, Danish Act on Health and the Helsinki II convention of clinical trials. The study will be announced at the clinicaltrials.gov homepage. All participants are informed about the purpose of the study, all ethical issues and a written consent is obtained before participation.

Personal data from patient medical files will be accessed by principal investigator to gather information concerning the knee injuries in order to identify and characterize the knee injury for each subject. Personal data concerning demographic relations such as gender and age will be accessed as well to ensure the case subjects meet the inclusion criteria and for statistically use. To make assessments on study participation, the principal investigator will also gain access to relevant data from the patient s medical files concerning illnesses or conditions the case subject might report. The X-ray radiation from 1 DXA scan equals 1 day of background radiation in Denmark. Thus 3 DXA scans throughout the study period are equal to 3 days of background radiation. This amount of radiation is 30-fold less than that of a single standard CT-scan of abdomen. In other words the dose of radiation is so low that a calculation of risk is not possible.

The amount of blood drawn during the approximately 16 weeks of participation in the study is less than 500 ml, which is the standard amount of blood drawn at a single donation of blood from a blood donor. The use of intravenous cannula can cause irritation or infection of vein or insertion site. All procedures will be performed as described in SOP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glucose Metabolism Disorders Lipid Metabolism Disorders Sedentary Lifestyle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case subjects

Physical active non-diabetic individuals of age 18 to 50 years, who are undergoing knee surgical procedures at the Arthroscopic Center at Amager/Hvidovre Hospitals are recruited as cases for this case-control study. OGTT, blood- and urine sampling and DXA scans will be performed 3 times throughout the study period.

Blood and Urine sampling

Intervention Type BIOLOGICAL

Blood and Urine Sampling

DXA scan

Intervention Type RADIATION

Scan of Lumbar columna and neck of femur/hip Scan of visceral/subcutaneous fatty tissue

OGTT

Intervention Type BIOLOGICAL

Oral Glucose Tolerance Test for Minimal Model analysis for insulin sensitivity and Lipid oxidation

Control group

Non-diabetic individuals matched for age, gender and physical activity are recruited as control subjects to establish a reference level likely to image the cases before they experienced their knee injury. Blood- and urine sampling, OGTT and DXA scans will be carried out 1-3 times for each control subject. No lifestyle intervention is implemented.

Blood and Urine sampling

Intervention Type BIOLOGICAL

Blood and Urine Sampling

DXA scan

Intervention Type RADIATION

Scan of Lumbar columna and neck of femur/hip Scan of visceral/subcutaneous fatty tissue

OGTT

Intervention Type BIOLOGICAL

Oral Glucose Tolerance Test for Minimal Model analysis for insulin sensitivity and Lipid oxidation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood and Urine sampling

Blood and Urine Sampling

Intervention Type BIOLOGICAL

DXA scan

Scan of Lumbar columna and neck of femur/hip Scan of visceral/subcutaneous fatty tissue

Intervention Type RADIATION

OGTT

Oral Glucose Tolerance Test for Minimal Model analysis for insulin sensitivity and Lipid oxidation

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals of age 18 to 50 years
* Physically active \>/= 1.5 hours/week up till baseline examination
* Physically active at least 2.5 hours/week before knee injury.
* The participants should undergo one of the following orthopaedic surgical procedures; Medial patella-femoral ligament (MPFL) surgery, Anterior Crusiate Ligament (ACL) and/or Posterior Crusiate Ligament (PCL) surgery, Knee Cartilage Injury surgery
* Informed written consent

Exclusion Criteria

* BMI \>/= 30 kg/m2
* Not physically active before surgical procedure as measured by questionnaire
* Known diabetes mellitus or HbA1c \>/= 48 mol/mol
* Clinical significant anemia, liver or kidney disease as judged by the sponsor or principal investigator.
* Thyroid function abnormality (TSH \< 0.1 or TSH \> 10)
* Calcium metabolic derangement, Ca++ \< 1.1 or Ca++ \> 1.40
* Known osteoporosis
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hölmich, Per, M.D.

INDIV

Sponsor Role collaborator

Haugaard, Steen Bendix, M.D., DMSc

INDIV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Per Hölmich, MD, DMSc

Role: PRINCIPAL_INVESTIGATOR

Amager Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amager University Hospital

Copenhagen, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Steen B Haugaard, MD, DMSc

Role: CONTACT

+45 53555066

Emilie K Kongebro, BMed

Role: CONTACT

+45 40152735

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Steen B Haugaard, MD, DMSc

Role: primary

+45 53555066

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AH-ORTHOMET-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.